Despite mistrust of the pharmaceutical industry, most people who participate in clinical trials are willing to have their data shared with researchers who work at drug companies, although concerns remain that the information may be used for marketing purposes, according to a new study.

Specifically, 44 percent of clinical trial participants who were queried indicated that they have little to no trust in drug makers, yet overall, 82 percent said they were very or somewhat likely to allow scientists at for-profit companies to access their data.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!


What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy